NCT02435732View on ClinicalTrials.gov

CINRYZE as a Donor Pre-treatment Strategy in Kidney Recipients of KDPI>60%

PHASE1UnknownINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

December 31, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2022

Conditions

Kidney Failure

Interventions

DRUG

Placebo saline solution

saline solution

DRUG

Heparin

Added to the one of the arms receiving 200U/kg dose of CINRYZE

DRUG

CINRYZE

200U/kg IV dose with or without heparin, or 500U/kg IV dose

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Shire

INDUSTRY

lead

University of Wisconsin, Madison

OTHER